|
Profile
|
Delegates :
Toru Okuda |

|
Incorporated :
August 31 , 2005 |
Paid in Capital :
10 Million yen |
Employees :
3 人 |
Address :
18-28, Tamagawagakuen 2 cho-me, Machida, Tokyo TOKYO
〒194-8610
|
TEL/FAX :
+81-428606258 / +81-428606259 |
URL:
http://www.hyphagenesis.co.jp/topen.html |
Attachment :
|
Mission/Background :
HyphaGenesis can provide with over 30,000 samples of an original fungal extract library with which you can easily access Japanese and Asian natural resources for drug, functional food or cosmetic developments. Our extracts are mostly accompanied with bioactivity data, such as anti-bacterial, anti-fungal, cell toxic and anti-oxidative activities.
We can provide with over 30,000 samples of an original fungal extract library with which you can easily access Japanese and Asian natural resources for drug, functional food or cosmetic developments. Our extracts are mostly accompanied with anti-bacterial, anti-fungal, and cell toxic activity data.
|
Technology & Business
|
● Supporting Lead/Seed discovery from HGI original microbial library We possess more than 20,000 newly isolated microbial strains - mainly filamentous fungi and wild mushrooms - from nature in Japan. We provide with their cultured extracts and extracts from fruiting bodies for pharmaceutical, cosmetic and functional food industries. ● Process development on chemical industry Our novel fermentation process applicable on chemical industries on the basis of metabolic engineering and molecular engineering technique has been developed for out-licensing. ● Development of functional material by OMICS We execute profiling of fungal secondary metabolites and strain improvement by OMICS technology.
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
ExMyco
|
Service/Marketing
|
Fungal strains originally isolated by HGI are grown in 4 from 8 types of solid/liquid media modified for the optimal metabolite
|
Selling to pharmaceutical, agrochemical, food and cosmetic companies
|
StrMyco
|
Service/Marketing
|
Ascomycetes, Basidiomycetes and fungi imperfecti, originally isolated from soil, rotten or living plants, bugs and mushrooms col
|
Selling to pharmaceutical, agrochemical, food and cosmetic companies
|
PowKinoco
|
Service/Marketing
|
Fruiting bodies of 1,200 edible, inedible or poisonous mushrooms are freeze-dried.
|
Selling to pharmaceutical, agrochemical, food and cosmetic companies
|
|
|
|
|
|
|
|
|
Highlights
|
2013 Government Grant "Production of carotenoids from mushroom" 2013 Government Grant "Production of drug candidates from fungi" 2009 Kanagawa Pref. Grant “Discovery project on protein kinase inhibitor as anticancer drug candidates” 2009 Governmental Grant “Production of biodegradable polymer materials” 2008 Collaboration with Yukiguni Maitake Co., Ltd. 2007 Grant from Yokohama city 2006 Grant from the Small and Medium Enterprise Agency
Patent application: 5
|
Alliance strategy
|
HyphaGenesis is interested in customers for sales of the library, collaboration partners for business development and customers for contracted trust screening research.
|
|
|